Evaluating comorbidity scoring systems for flumatinib therapy in chronic myeloid leukemia: a machine learning and SHAP-based predictive analysis - Quiz - MDSpire

Evaluating comorbidity scoring systems for flumatinib therapy in chronic myeloid leukemia: a machine learning and SHAP-based predictive analysis

  • By

  • Yuanlan Yang

  • Yujun Li

  • Jishi Wang

  • May 28, 2026

  • 0 min

Share

Original Source(s)

Evaluating comorbidity scoring systems for flumatinib therapy in chronic myeloid leukemia: a machine learning and SHAP-based predictive analysis

  • by Yuanlan Yang, Yujun Li, Jishi Wang

  • May 28, 2026

Related Content

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

Management of toxicities from antibody – drug conjugates in breast cancer

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases